Psoriasis and the TNF/IL23/IL17 axis

Kazuhisa Furue, Takamichi Ito, Gaku Tsuji, Takafumi Kadono, Masutaka Furue

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The excellent response of psoriasis to anti-TNF-α(TNF)/IL23/IL17A biologics implies a crucial role for the TNF/IL23/IL17 axis in developing psoriasis. In addition to the TNF/IL23/IL17 axis provided by immune cells, current evidence points to an important contribution of TNF, IL23 and IL17C produced from non-hematopoietic keratinocytes. Therefore, crosstalk between immune cells and keratinocytes forms a multilayered feed-forward loop to accelerate the TNF/IL23/IL17A axis. Many biologics have already been licensed or are under clinical trials. Given that the IL-17 signature is more upregulated in the skin than in synovium in psoriatic arthritis, anti-IL-23/IL-17 agents seem to be superior to anti-TNF-α remedies in the treatment of skin lesions. In this review, we summarize recent topics in psoriasis and the TNF/IL23/IL17 axis.

Original languageEnglish
Pages (from-to)418-424
Number of pages7
JournalGiornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia
Volume154
Issue number4
DOIs
Publication statusPublished - Aug 1 2019

Fingerprint

Psoriasis
Interleukin-17
Biological Products
Keratinocytes
Interleukin-23
Skin
Psoriatic Arthritis
Synovial Membrane
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Psoriasis and the TNF/IL23/IL17 axis. / Furue, Kazuhisa; Ito, Takamichi; Tsuji, Gaku; Kadono, Takafumi; Furue, Masutaka.

In: Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, Vol. 154, No. 4, 01.08.2019, p. 418-424.

Research output: Contribution to journalArticle

@article{c338eed7aeff4e8dacaf9b3c2baed3fa,
title = "Psoriasis and the TNF/IL23/IL17 axis",
abstract = "The excellent response of psoriasis to anti-TNF-α(TNF)/IL23/IL17A biologics implies a crucial role for the TNF/IL23/IL17 axis in developing psoriasis. In addition to the TNF/IL23/IL17 axis provided by immune cells, current evidence points to an important contribution of TNF, IL23 and IL17C produced from non-hematopoietic keratinocytes. Therefore, crosstalk between immune cells and keratinocytes forms a multilayered feed-forward loop to accelerate the TNF/IL23/IL17A axis. Many biologics have already been licensed or are under clinical trials. Given that the IL-17 signature is more upregulated in the skin than in synovium in psoriatic arthritis, anti-IL-23/IL-17 agents seem to be superior to anti-TNF-α remedies in the treatment of skin lesions. In this review, we summarize recent topics in psoriasis and the TNF/IL23/IL17 axis.",
author = "Kazuhisa Furue and Takamichi Ito and Gaku Tsuji and Takafumi Kadono and Masutaka Furue",
year = "2019",
month = "8",
day = "1",
doi = "10.23736/S0392-0488.18.06202-8",
language = "English",
volume = "154",
pages = "418--424",
journal = "Giornale Italiano di Dermatologia e Venereologia",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Psoriasis and the TNF/IL23/IL17 axis

AU - Furue, Kazuhisa

AU - Ito, Takamichi

AU - Tsuji, Gaku

AU - Kadono, Takafumi

AU - Furue, Masutaka

PY - 2019/8/1

Y1 - 2019/8/1

N2 - The excellent response of psoriasis to anti-TNF-α(TNF)/IL23/IL17A biologics implies a crucial role for the TNF/IL23/IL17 axis in developing psoriasis. In addition to the TNF/IL23/IL17 axis provided by immune cells, current evidence points to an important contribution of TNF, IL23 and IL17C produced from non-hematopoietic keratinocytes. Therefore, crosstalk between immune cells and keratinocytes forms a multilayered feed-forward loop to accelerate the TNF/IL23/IL17A axis. Many biologics have already been licensed or are under clinical trials. Given that the IL-17 signature is more upregulated in the skin than in synovium in psoriatic arthritis, anti-IL-23/IL-17 agents seem to be superior to anti-TNF-α remedies in the treatment of skin lesions. In this review, we summarize recent topics in psoriasis and the TNF/IL23/IL17 axis.

AB - The excellent response of psoriasis to anti-TNF-α(TNF)/IL23/IL17A biologics implies a crucial role for the TNF/IL23/IL17 axis in developing psoriasis. In addition to the TNF/IL23/IL17 axis provided by immune cells, current evidence points to an important contribution of TNF, IL23 and IL17C produced from non-hematopoietic keratinocytes. Therefore, crosstalk between immune cells and keratinocytes forms a multilayered feed-forward loop to accelerate the TNF/IL23/IL17A axis. Many biologics have already been licensed or are under clinical trials. Given that the IL-17 signature is more upregulated in the skin than in synovium in psoriatic arthritis, anti-IL-23/IL-17 agents seem to be superior to anti-TNF-α remedies in the treatment of skin lesions. In this review, we summarize recent topics in psoriasis and the TNF/IL23/IL17 axis.

UR - http://www.scopus.com/inward/record.url?scp=85067114630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067114630&partnerID=8YFLogxK

U2 - 10.23736/S0392-0488.18.06202-8

DO - 10.23736/S0392-0488.18.06202-8

M3 - Article

C2 - 30648836

AN - SCOPUS:85067114630

VL - 154

SP - 418

EP - 424

JO - Giornale Italiano di Dermatologia e Venereologia

JF - Giornale Italiano di Dermatologia e Venereologia

SN - 0392-0488

IS - 4

ER -